Etretinate FDA Link

An oral retinoid used in the treatment of keratotic genodermatosis, lichen planus, and psoriasis. Beneficial effects have also been claimed in the prophylaxis of epithelial neoplasia. The compound may be teratogenic.

Also Known As:

B10-9359; Ethyl Etrinoate; Ro 10-9359; Ro-10-9359; Tigason; Tigazon; B10 9359; B109359; Etrinoate, Ethyl; Ro 10 9359; Ro 109359; Ro109359; 2,4,6,8-Nonatetraenoic acid, 9- (4- methoxy- 2,3,6- trimethylphenyl)- 3,7- dimethyl- , ethyl ester, (all-E)-

Pharmalogical Action Categories:

Keratolytic Agents

Organic Chemicals: 133
- Hydrocarbons: 1713
  - Terpenes: 1461
    - Carotenoids: 4095
      - Retinoids: 5957
        Etretinate: 752
  - Acyclic Hydrocarbons
    - Alkenes: 265
      - Polyenes: 164
        Carotenoids: 4095
        Retinoids: 5957
        Etretinate: 752
Biological Factors: 2472
- Biological Pigments: 1
  - Carotenoids: 4095
    - Retinoids: 5957
      - Etretinate: 752

Etretinate Products